The combined effect of β-tricalcium phosphate and basic fibroblast growth factor was observed in the regeneration of periodontal tissue in dogs. For this purpose, either β-TCP and FGF-2 (β-TCP/FGF-2 group) or FGF-2 alone (FGF-2 group) was applied in intrabony defects. The control group received β-TCP alone. The tissues were histologically examined at 2, 4, or 8 weeks following treatment. The control group was characterized by incomplete, newly formed bone around β-TCP particles. The β-TCP/FGF-2 group showed a statistically significant increase in both new bone and cementum formation compared to the FGF-2-alone group (76.3% vs. 65.3%, p<0.01; 81.0% vs. 68.3%, p<0.01, respectively). These findings suggested that β-TCP may be a suitable scaffold for FGF-2 and that the combination of β-TCP and FGF-2 can enhance bone and cementum formation.
INTRODUCTION
The aim of periodontal tissue regeneration is to restore supporting periodontal tissue destroyed by periodontal disease. Various growth factors have been demonstrated to be effective in periodontal tissue regeneration in animal experiments [1] [2] [3] [4] [5] [6] [7] [8] . Cytokine therapy with growth factors has been suggested to induce a wound healing cascade characterized by well-regulated cellular events 9) . For example, basic fibroblast growth factor (FGF-2) induces angiogenesis, chemotaxis, and the proliferation of periodontal ligament cells 10) . On this note, Murakami et al. 11) reported that FGF-2 enhanced periodontal tissue regeneration in experimental alveolar bone defects in beagles, suggesting that it plays an important role in the periodontal tissue regeneration process. Furthermore, even when a solution containing no scaffold was applied, Murakami et al. 12) reported that FGF-2 clearly induced periodontal tissue regeneration. However, for practical applicability in periodontal surgery, it is preferable that FGF-2 be available in the form of a viscous gel. Therefore, the development of an ideal scaffold for FGF-2 that would provide osteoconductive scaffolding for undifferentiated mesenchymal cells might markedly promote its application in dental and craniofacial medicine. Owing to their biocompatibility and osteoconductivity, a number of calcium phosphate biomaterials have been developed as bone substitutes. Of these materials, β-tricalcium phosphate (β-TCP) has been shown to exhibit good biocompatibility and osteoconductivity in both animal and clinical studies [13] [14] [15] [16] [17] [18] . Ogose et al. 17) reported that this material showed marked osteoconductivity and was absorbed by a cellmediated process in the early phase after implantation in rat femoral condyle. Besides, it also exhibited marked osteoconductivity and bioabsorbability after implantation in human bone. Although β-TCP is commonly used as an osteoconductive material to provide the basic physical scaffolding for the ingrowth of bone-forming cells 19) , applicability of β-TCP in the treatment of osseous defects seems to have great potential for expansion when used in conjunction with FGF-2. The adsorption of plateletderived growth factor (PDGF) to β-TCP material has been shown to support osteoblastic cell attachment and to increase proliferation in vitro 20) . The objective of this study was to determine the effect of β-TCP on the regeneration of periodontal tissue via a combination of β-TCP particles and FGF-2.
MATERIALS AND METHODS

Preparation of intrabony defect sites
Fifteen young, healthy male beagle dogs were used in this study.
All experiments were conducted in accordance with the guidelines for the treatment of experimental animals at Tokyo Dental College. At 16 weeks prior to the start of the experiment, the mandibular third premolars were extracted and the extraction sites were allowed to heal for 4 weeks. At 12 weeks before the experimental day 0, the following treatment was carried out. Buccal and lingual mucoperiosteal flaps were elevated to surgically create "box-type" two-wall intrabony defects (5×5×5 mm) (Fig. 1A) at the distal aspect of the second and the mesial aspect of the fourth mandibular premolars, in either the right or left jaw quadrants. To prevent spontaneous healing and enhance plaque accumulation, a rubber base impression material was placed in each defect. At 4 weeks after treatment, namely 8 weeks before experimental day 0, the rubber base impression material was removed.
Treatment of intrabony defects with graft materials
At experimental day 0, full-thickness mucoperiosteal flaps were raised, granulation tissue was removed, and the root surfaces facing the defects were scaled and planed. Using a small round bur, reference notches indicating the bottom of the defect were prepared on the root surfaces. The intrabony defects were then randomly assigned to one of following groups (six sites in each group): FGF-2-alone group, treated with 200 μg of FGF-2 (Scios Nova, Mountain View, CA, USA) and hydroxypropyl cellulose (HPC) solution; β-TCP/FGF-2 group, where β-TCP used this study was whitish in color with a macropore size of 100-400 μm, diameter of 0.5-1.5 mm, and porosity of 75％ (Fig. 2) , (OSferion ® , Olympus Terumo Biomaterials Corp., Tokyo, Japan); and a control group (β-TCP alone). In β-TCP and FGF-2-alone groups, the graft materials were placed such that they loosely filled each defect. In β-TCP/FGF-2 group, FGF-2 was applied to the root surfaces and β-TCP while β-TCP completely filled the defects (Fig. 1B) . Finally, the flaps were replaced and sutured coronally with vertical or horizontal mattress sutures. The animals were euthanized with an intravenously administered overdose of sodium pentobarbital (NEMBUTAL ® , Dainihonseiyaku, Osaka, Japan) at 2, 4, or 8 weeks after the treatment. The implants and surrounding tissues were removed and fixed in 10％ formalin. Samples were decalcified with 10％ ethylenediamine tetraacetic acid (EDTA; Wako, Tokyo, Japan) for 5 months and then dehydrated in ethanol, embedded in paraffin, and serially sectioned (to 5 μm thickness) in a mesiodistal orientation. The sections were then stained with hematoxylin-eosin. Serial sections were also stained with tartrateresistant acid phosphatase (TRAP). 
Scanning electron microscopy (SEM)
The surface morphology of β-TCP was observed under a scanning electron microscope (SEM; ERA-8900FE, ERIONIK, Tokyo, Japan). The samples were coated with Au-Pd alloy. Accelerating voltage was set at 15.0 kV.
Morphometric analysis
Five sections from each root were used for microscopic examination and histometric assessment at ×40 magnification. The following features were quantitatively assessed ( Fig. 3 ): apical notch to bone crest (New bone: NB), apical notch to newly formed cementum (New cementum: NC), and apical notch to cement-enamel junction (LD). The percentage of each major tissue type filling the original defect (e.g., New bone and New cementum) was calculated according to the following formula: cross-sectional length of each tissue type divided by cross-sectional length of original defect (e.g., New bone (％) = NB/ LD; New cementum (％) = NC/LD). These measurements were statistically analyzed using the Scheffé's test (n=6) to determine the effects of graft materials on histometric parameters.
RESULTS
Histological observations
1. Control group At 8 weeks after surgery, periodontal regeneration was limited to the bottom of the bone defects ( Fig.  4A-1) . Incomplete newly formed bone was observed around the β-TCP particles within the bone defects, accompanied with the coronal portion of the defects closed by fibrous tissue (Fig. 4A-2 ).
2. Experimental groups 2.1 FGF-2-alone group At 2 weeks after surgery, a small amount of new bone formation was observed at the base of the defects (Fig. 4B) . Maturation of granulation tissue and a lamellar structure of newly formed bone were observed in the defects. At 4 weeks after surgery, increased new bone formation was found within the defects, which were filled with connective tissue at the coronal portion (Fig. 4C ). Significant periodontal ligament formation with new cementum deposition and new bone formation were observed in all sites. At 8 weeks after surgery, new bone formation occurred at the apical portion of the defects, while the middle and upper parts of the defects were surrounded by dense connective tissue ( Fig. 4D-1 ). Newly formed cementum was present from the notch of the root surface to the coronal portion ( Fig. 4D-2 ). 2.2 β-TCP/FGF-2 group At 2 weeks after surgery, bone defects were filled with newly formed connective tissue composed of fibroblast cells and capillaries ( Fig. 5A-1) . Most of the implanted β-TCP particles remained within the defects, surrounded by numerous fibroblast cells and capillaries ( Fig. 5A-2) .
The newly formed bone reached some of the implanted β-TCP particles. Abundant multinucleated cells adhered to the β-TCP particles, not only at the base of the defects, but also in the central region of the implanted areas ( Fig. 5A-2) . Most of the TRAP-positive cells were mononuclear giant cells located around the β-TCP particles (Fig.  5A-3) . The number of TRAP-positive cells reached a peak at 2 weeks. At 4 weeks after surgery, new bone formation increased and many β-TCP particles in the defects were surrounded by new bone tissue (Fig. 5B-1) . Extensive proliferation of capillaries was observed in the area adjacent to the new bone ( Fig. 5B-2 ). Newly formed bone was detected around the β-TCP particles: the bone matrix was stained positively by eosin and cuboidal osteoblasts were observed to be in contact with the new bone. Some multinucleated giant cells were in contact with the surface of the β-TCP particles (Fig. 5B-2) . Active new bone formation occurred with numerous multinucleated giant cells seen in relation to the resorption of β-TCP (Fig. 5B-2) . A layer of newly formed cementum extended from the apical notch of the root surface to the coronal portion (Fig. 5B-3) . At 8 weeks after surgery, β-TCP particles were embedded within the bone tissue and newly formed bone, which had originated from the base of the defects (Fig. 5C-1) . Bone marrow tissue was observed in new bone ( Fig. 5C-2 ). The width of the newly formed bone was thicker and the area of β-TCP particles became smaller. New bone and cementum formation was observed to extend to the coronal portion ( Fig. 5C-3) . A well-organized periodontal ligament space was observed between the teeth and the newly formed bone (Fig. 5C-3) . No marked root resorption or ankylosis was observed. Table 1 shows the morphometric results. The β-TCP/FGF-2 group yielded periodontal regeneration of new cementum at 81.0％ ± 2.1％ and new bone at 76.3％ ± 6.3％. In contrast, new cementum and new bone increased by only 68.3％ ± 4.0％ and 65.3％ ± 5.8％, respectively, in the FGF-2-alone group. This demonstrated that new cementum and bone formation in the β-TCP/FGF-2 group were significantly higher (p<0.01) than in the FGF-2-alone group. Similarly, new cementum and bone formation were significantly higher in the FGF-2-alone group than in the control group (p<0.01). 
Morphometric measurements
DISCUSSION
The 12) , who investigated the effect of FGF-2 on postoperative periodontal tissue wound healing. It was found that FGF-2 stimulated the residual periodontal cells during the early phase of wound healing, promoting an inflammatory reaction which subsequently enhanced periodontal tissue regeneration 12) . Taken together, these findings indicated that a combination treatment involving both β-TCP particles and FGF-2 induced new cementum and bone formation, thus facilitating the wound healing process. Moreover, the β-TCP/FGF-2 complex induced better local conditions than FGF-2 alone. In this study, the microstructure of porous β-TCP matrix led to vascularization of the matrix itself -and this might have been the most important geometrical factor in FGF-2-induced osteogenesis. Prior studies with β-TCP matrix 21, 22) suggested that pore sizes ranging between 100 and 300 μm allowed relatively uninhibited bone growth and the development of a good vascular network, permitting normal remodeling processes to take place. In this study, pore sizes as large as 100 to 400 μm were found.
Consequently, the pore size might have influenced osteoconduction, suggesting that the study material used possessed favorable characteristics for its intended use as a scaffold. Indeed, over the course of 4 weeks with FGF-2/β-TCP, many osteoblasts were observed to attach via the pores of the material.
Once it was established that the β-TCP matrix was osteoconductive and that it supported the attachment of osteoblasts, and that FGF-2 was absorbed by the matrix, the effect of this matrixenhanced osteoblastic cell proliferation was studied in vitro 23, 24) . Results of this study revealed that adhesion of osteoblastic cells was greater with FGF-2/β-TCP matrix than withβ-TCP matrix alone. This suggested that β-TCP matrix offers greater absorbance of FGF-2 than other matrices. Several capillary blood vessels appeared adjacent to the β-TCP particles at 1 week after implantation. At 2 weeks, the number of capillary vessels showed an increase -suggesting that FGF-2 induced capillary vessel formation early after application. On the potential of PDGF to enhance the osteogenic capabilities of β-TCP, a study by Bateman et al. 20) showed that β-TCP was capable of releasing preadsorbed PDGF, resulting in a significantly increased osteoblastic proliferative response in vitro. Taken together with the findings of this study, it was thus suggested that the adsorption of FGF-2 to β-TCP particles increased neovascularization and proliferation of periodontal ligament cells. When surgical stress is loaded on periodontal tissue, perivascular cells rapidly proliferate around blood vessels and migrate to the wound 25) . The potent angiogenic activity of FGF-2 during wound healing may then be induced by the undifferentiated mesenchymal stem cells 26) .
On the use of TRAP staining for new bone formation observation, Eggli et al. 27) demonstrated that osteoclast-like cells showed a positive TRAP reaction in regions of active β-TCP absorption in rabbit femoral implant sites. Indeed, monocytes and macrophages, including osteoclast-like cells, were constantly seen to adhere to and absorb the β-TCP particles. In the same vein, Minkin 28) reported that osteoclasts released TRAP during bone resorption, and hence TRAP activity has been used as an enzyme marker of osteoclasts. In this study, TRAP-positive cells were observed near β-TCP particles at 2 weeks after implantation. At 2-4 weeks after implantation, hematoxylin-eosin staining revealed numerous multinucleated giant cells on the surface of β-TCP particles, and these cells were mostly TRAP stainingpositive in serial sections. Results of this study thus suggested that osteoclasts played an important role in β-TCP absorption in the early phase. On the absorption of β-TCP particles, there are two known bioabsorption mechanisms: dissolution and cellmediated disintegration 29) . Bhasker et al. 30) showed that mesenchymal cells were clearly involved in the cellular mechanism of degradation. The number of TRAP-positive cells in this study corresponded with the amount of residual β-TCP in the defects. In addition, several multinucleated giant cells and osteoblasts were already present and clustered in the space between the new bone and β-TCP particles at 4 weeks after implantation. It is long recognized that the balance between bone resorption by osteoclasts and bone formation by osteoblasts is a tightly coupled one 15) , which meant that the absorption of β-TCP particles by multinucleated giant cells was probably followed by the emergence of osteoblasts.
In the β-TCP/FGF-2 complex, numerous osteoclasts were seen to be in contact with the β-TCP particles.
Similarly in preliminary experiments, a small number of osteoclasts was observed to be in contact with the β-TCP particles in the β-TCP-alone group. The time lag of most TRAP-positive cells was 2-4 weeks, but new bone formation rate peaked at 4-8 weeks. This indicated that new bone formation was induced via β-TCP absorption by osteoclasts, and that the coupling phenomenon occurred in the β-TCP-filled bone defects. As a result, osteoblasts were present in new bone at 4 weeks after implantation, indicating that these cells were active. At 8 weeks, normal bone marrow tissue was noted in the implanted region and new bone was not resorbed, showing that the β-TCP/FGF-2 complex was a good biomaterial, maintaining desirable conditions for long-term bone formation and resorption.
In conclusion, β-TCP particles were fully incorporated into the trabeculae of new bone, being slowly absorbed to obtain the optimum mechanical strength needed, and finally replaced by mature bone. This indicated that β-TCP is useful as a scaffold for new bone formation, functioning as a medium for arrangement and support of FGF-2 in bone defects.
